1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
| {
| "batch_id": "BATCH-STOCK-VALUATION-QINGFENGPU-TIMELINE-20260825-001",
| "ticker": "600613.SH",
| "company": "神奇制药",
| "as_of": "2026-08-25",
| "v2_status": "BLOCKED",
| "v2_failure": {
| "complete": false,
| "error": "SourceContractError: 网络请求失败：Remote end closed connection without response",
| "error_code": "E_CORE_INPUT",
| "error_type": "CoreInputError",
| "recorded_at": "2026-08-25T19:57:12.418+08:00",
| "rollback_errors": [],
| "run_id": "f7c3abfd1323494ebbe107cf342edc38",
| "schema_version": 2,
| "status": "BLOCKED"
| },
| "v2_runtime_package": "v2_600613_SH.failed-f7c3abfd1323494ebbe107cf342edc38",
| "v2_raw_artifact_hashes": [
| "56513a8652fcf5a19d54f1aeefdbe0dc90121ae3b3b023492bb4d324442e0b65",
| "5be312c12aa0517873028edc55b7436baa488bb18cf2c3ea3adf4d1784fec913",
| "725eba7b77d7d9d45b0ec6d31edfa63179b51f2e8825544f879564fb07f17450",
| "a02b976e06f4e4d6d4e1526a3085c830769a17fea2bbd665d08170014a1d11c0",
| "d32f0772726793e1884aa0c21d76578f90ddbd0b0b2408adfa8b4a141aa6d199",
| "ea6528a2204b61a7ee34683a73ca00f8afdc86aadf3f765d4dae39bbfb19dbe7",
| "ee0f619f22babf5ce9836d670e82d5542fbc8aed9efcedd32bf26b3fd6abc537",
| "feb3bd35cb34f326e00a0045fed07b72d0cc3704acba3e334e582034c6b1f38a"
| ],
| "market_contract": {
| "table": "trading_xuntou.cn_stock_kline_1d_front",
| "source": "xtquant",
| "source_batch_id": "FKL_20260825_161021_6bd1f63d_1d_20260825_00012",
| "updated_at": "2026-08-25 16:38:32",
| "trade_date": "2026-08-25"
| },
| "quote_raw_hash": "",
| "share_proof": {
| "shares": 534071628.0,
| "shares_fallback": true,
| "shares_fallback_source": "statutory_report:report_shares",
| "report_shares": 534071628.0,
| "share_unit_correction": null,
| "static_total_shares": 534071628.0,
| "match_report": true,
| "quote_market_cap": null,
| "price_times_shares": 5484915619.559999,
| "gap_rate": 0.0
| },
| "industry_membership": {
| "industries": [
| "医药"
| ],
| "layers": [
| "overview",
| "reverse:医药、创新药与疫苗",
| "timeline"
| ],
| "research_name": "神奇制药"
| },
| "bounded_gaps": [
| "V2 quote f124=0，端到端流程诚实阻断；正式估值用当前总股本/市值勾稽，股本历史日期无A1完全匹配时显式保留缺口。",
| "机构汇总缺逐家报告日期与明细，不把一致预期写成法定事实。"
| ],
| "checks": {
| "v1_qa": {
| "error_count": 0,
| "info_count": 1,
| "issues": [
| {
| "action": "补充法定披露、行情接口或机构预测汇总页来源。",
| "field": "institutions",
| "issue_id": "QA-CORE-SOURCE-MISSING",
| "message": "核心字段没有由注册表中允许承载核心数字的来源支持。",
| "recalc_scope": "institutions",
| "severity": "WARNING"
| },
| {
| "action": "不得以公司业绩预告或自有情景冒充机构预期。",
| "field": "institutions",
| "issue_id": "QA-INSTITUTION-NONE",
| "message": "估值日没有可用机构盈利预测，已明确记录为空。",
| "recalc_scope": "机构预期模块",
| "severity": "INFO"
| }
| ],
| "status": "PASS_WITH_WARNINGS",
| "warning_count": 1
| },
| "label": "明显偏贵",
| "base_low": 0.9326199329296706,
| "base_high": 2.2858331689452713,
| "optimistic_high": 4.416229682402264,
| "price": 10.27,
| "bubble_status": "泡沫-极端"
| }
| }
|
|
